Key takeaways
Emtriva (emtricitabine) and Epzicom (abacavir/lamivudine) are both medications used to treat HIV. They belong to the same class of medications called nucleoside reverse transcriptase inhibitors (NRTIs), which work by stopping the virus from making copies of itself. Emtriva is a single medication, while Epzicom is a combination of two medications. Emtriva is available as a capsule and an oral solution, whereas Epzicom is available as a tablet. Both medications are often used in combination with other HIV medications for treatent of HIV. Both medications are available in generic form, which can be more affordable. Both medications can cause liver problems and worsening of hepatitis B if stopped suddenly, but Epzicom also requires a genetic test to check for a risk of severe allergic reactions. Common side effects of Emtriva include nausea and fatigue, while Epzicom can cause headaches and nausea.
